Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada

BMC Infectious Diseases

Table 1 Demographic characteristics participants by HBV infection status (N = 2419)

Demographic Characteristics	HIV N = 2220	HIV-HBV Co-Infection N = 199	p value^a
Median Age	40 (32.0–46.0)	39 (33.0–45.0)	0.69
Male Sex	1806 (81)	164 (82)	0.71
Deceased	150 (7)	22 (11)	0.02
Ethnicity
White	967 (44)	78 (39)	0.11
Black	408 (18)	50 (25)
Indigenous	138 (6)	10 (5)
Asian	147 (7)	20 (10)
Hispanic	116 (5)	9 (5)
Other	82 (4)	5 (3)
Unknown	362 (16)	27 (14)
Province
BC	946 (43)	88 (44)	0.49
ON	870 (39)	70 (35)
QC	404 (18)	41 (21)
Risk Factors
MSM	998 (45)	93 (47)	0.63
PWID	467 (21)	55 (28)	0.03

BC British Colombia, ON Ontario, QC Quebec, MSM Men who have sex with men, PWID people who inject drugs, ADI AIDS defining illness, ARV anti-retroviral therapy
^aData shown are frequencies and proportions for categorical variables and median and interquartile ranges for continuous variables. p values for categorical variables were calculated using chi-square or Fisher exact tests and for continuous variables were calculated using Wilcoxon’s Rank Sum tests
^b‘No ADI ever’ refers to no recorded ADI’s during study period. ‘None before/or first ARV date’ refers to no recoded ADI prior to study enrollment

ISSN: 1471-2334